SEC Info - ENDRA Life Sciences Inc. - ‘S-3’ on 3/25/21

SEC Info℠

Home

Help

Please Sign In

ENDRA Life Sciences Inc. – ‘S-3’ on 3/25/21 – ‘EX-23.1’

On: Thursday, 3/25/21, at 5:07pm ET · Accession #: 1654954-21-3303 · File #: 333-254711

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/25/21  ENDRA Life Sciences Inc.          S-3                    4:992K                                   Blueprint/FA

Registration Statement – Securities for a Transaction — Form S-3 — SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement - Securities for a           HTML    192K 
                Transaction                                                      
 2: EX-4.9      Form of Indenture                                   HTML    346K 
 3: EX-5.1      Opinion of K&L Gates LLP as to Legality of          HTML     30K 
                Securities Being Registered                                      
 4: EX-23.1     Consent of Rbsm LLP, Independent Registered Public  HTML      7K 
                Accounting Firm

‘EX-23.1’ — Consent of Rbsm LLP, Independent Registered Public Accounting Firm

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

C: C:

ndra_ex231

Exhibit 23.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in this Registration Statement of ENDRA Life Sciences Inc. (the “Company”) on Form S-3 of our report, which includes an explanatory paragraph regarding the substantial doubt about the Company's ability to continue as a going concern, dated March 25, 2021, relating to the consolidated financial statements of ENDRA Life Sciences Inc. and subsidiaries, appearing in the Annual Report on Form 10-K of ENDRA Life Sciences Inc. for the year ended December 31, 2020. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.

/s/ RBSM LLP

RBSM LLP

New York, NY

March 25, 2021

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3’ Filing	Date	Other Filings

Filed on:	3/25/21	10-K, 4, 8-K, S-8
	12/31/20	10-K
		List all Filings

3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/18/20  ENDRA Life Sciences Inc.          8-K:5,9     6/16/20    2:54K                                    Blueprint/FA
 7/02/18  ENDRA Life Sciences Inc.          8-K:1,2,3,7 6/28/18    7:706K                                   Blueprint/FA
11/21/16  ENDRA Life Sciences Inc.          S-1        11/18/16   29:4.1M                                   Blueprint/FA

↑Top

Filing Submission 0001654954-21-003303 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)